Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

TPEX/7762 stock hub

TPEX/7762 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/7762is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.7B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/7762

In the news

Latest news · TPEX/7762

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E103.7

P25 n/aP50 n/aP75 n/a

ROE2.8

P25 n/aP50 n/aP75 n/a

ROIC0.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/7762 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

TWD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 2.3B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	TWD 2.7B
Price	TWD 47.7
Price currency	TWD
Sic	2836
Symbol	tpex/7762
Website	https://www.petpharmbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.92%
EV Earnings	93.61x
EV/EBIT	158.64x
EV/EBITDA	49x
EV/FCF	488.4x
EV/Sales	10.53x
FCF yield	0.18%
P/B ratio	2.28x
P/E ratio	103.7x
P/S ratio	12.3x
PE Ratio3 Y	155.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.64%
EBITDA Margin	17.2%
FCF margin	2.16%
Gross margin	52.44%
Gross Profit	TWD 116.4M
Gross Profit Growth	40.45%
Gross Profit Growth Q	82.34%
Gross Profit Growth3 Y	48.08%
Net Income	TWD 25M
Net Income Growth	72.25%
Net Income Growth Q	51.48%
Pretax Margin	10.89%
Profit Margin	11.25%
ROA	0.87
ROCE	1.14
ROE	2.8
ROIC	0.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-11.65%
EPS Growth	28.44
EPS Growth Q	9.66
FCF Growth Q	1,674.14%
OCF Growth	18.75%
OCF Growth Q	-4.99%
Revenue Growth	69.88x
Revenue Growth Q	84.28x
Revenue Growth3 Y	43.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.21
Assets	TWD 1.3B
Cash	TWD 518.9M
Current Assets	TWD 600.6M
Current Liabilities	TWD 56.2M
Debt	TWD 106.2M
Debt EBITDA	TWD 2.22
Debt Equity	TWD 0.09
Debt FCF	TWD 22.17
Equity	TWD 1.2B
Interest Coverage	16.53
Liabilities	TWD 151.4M
Long Term Assets	TWD 746.5M
Long Term Liabilities	TWD 95.1M
Net Cash	TWD 412.7M
Net Cash By Market Cap	TWD 15.12
Net Cash Growth	69.1%
Net Debt EBITDA	TWD -10.81
Net Debt Equity	TWD -0.35
Net Debt FCF	TWD -86.18
Tangible Book Value	TWD 1.1B
Tangible Book Value Per Share	TWD 18.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.68
Inventory Turnover	7.46
Net Working Capital	TWD 37M
Quick ratio	10.28
Working Capital	TWD 544.3M
Working Capital Turnover	TWD 0.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-32.26%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	TWD 0.25
Dividend Years	2
Dividend Yield	0.52%
Ex Div Date	2025-08-25
Last Dividend	TWD 0.09
Payout Frequency	Annual
Payout Ratio	20.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-11.64%
200-day SMA	65.85
50-day SMA	54.45
50-day SMA vs 200-day SMA	50under200
All Time High	91.2
All Time High Change	-47.75%
All Time High Date	2025-09-25
All Time Low	27.14
All Time Low Change	75.6%
All Time Low Date	2024-08-05
ATR	1.45
Beta1y	0.54
Beta2y	0.53
Ch YTD	-31.93
High	47.7
High52	91.2
High52 Date	2025-09-25
High52ch	-47.7%
Low	46.85
Low52	46.85
Low52 Date	2026-05-08
Low52ch	1.81%
Ma50ch	-12.48%
Price vs 200-day SMA	-27.64%
RSI	22.62
RSI Monthly	54.32
RSI Weekly	27.57
Sharpe ratio	-0.36x
Sortino ratio	-0.38
Total Return	-31.74%
Tr YTD	-31.93
Tr1m	-2.76%
Tr1w	-3.05%
Tr3m	-26.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 14.7M
Operating Income Growth	52.46
Operating Income Growth Q	76.29
Operating margin	6.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,620,804%
Net Borrowing	-107,800,000
Shares Insiders	10.37%
Shares Institutions	3.01%
Shares Out	57,233,000
Shares Qo Q	11.55%
Shares Yo Y	32.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 4.2M
Average Volume	61,601.3x
Bv Per Share	20.51
CAPEX	TWD -29.5M
Ch1m	-2.76
Ch1w	-3.05
Ch1y	-13.46
Ch3m	-26.01
Ch6m	-28.56
Change	0.1%
Change From Open	0
Close	47.65
Days Gap	0.1
Depreciation Amortization	23,445,000
Dollar Volume	1,590,890.4
Earnings Date	2026-05-14
EBIT	TWD 14.7M
EBITDA	TWD 38.2M
EPS	TWD 0.46
F Score	6
FCF	TWD 4.8M
FCF EV Yield	0.2x
FCF Per Share	TWD 0.08
Financing CF	454,180,000
Fiscal Year End	December
Founded	2,011
Goodwill	8,240,000
Graham Number	14.57115
Graham Upside	-69.42
Income Tax	TWD -723,000
Investing CF	-401,609,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Last Split Date	2025-08-25
Last Split Type	Forward
Ma150	65.81
Ma150ch	-27.59%
Ma20	49.06
Ma20ch	-2.88%
Net CF	86,867,000
Next Earnings Date	2026-05-14
Open	47.7
P FCF Ratio	570.1
P OCF Ratio	79.6
Payment Date	2025-10-14
Position In Range	100
Ppne	395,061,000
Price Date	2026-05-08
Price EBITDA	TWD 71.49
Ptbv Ratio	2.53
Relative Volume	0.54x
Revenue	222,032,000x
SBC By Revenue	0.28x
Share Based Comp	618,000
Tax By Revenue	-0.33x
Tr6m	-28.56%
Volume	33,352
Z Score	13.21

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/7762 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.25 annual per share

Payout ratio

+20.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

-31.7%

Next ex-dividend date: 2025-08-25

Performance

TPEX/7762 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/7762?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.0%

Share of float held by funds and institutions

Insider ownership

+10.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+32.3%

Negative means the company is buying back shares.

Technical

TPEX/7762 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

22.6

Below 30: short-term oversold

Price vs 200-day MA

-27.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/7762

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/7762 stock rating?

tpex/7762 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/7762 analysis?

The full report lives at /stocks/tpex/7762/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/7762?

The latest report frames tpex/7762 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/7762 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.